FDA Drug Application (021025) for EXELON by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number021025
Product Number001
FormSOLUTION;ORAL
DosageEQ 2MG BASE/ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEXELON
Active IngredientRIVASTIGMINE TARTRATE

Active IngredientCount
List of drugs with Active Ingredient RIVASTIGMINE2
List of drugs with Active Ingredient RIVASTIGMINE TARTRATE3


Back to FDA Applications sponsored by NOVARTIS